PRAX

Praxis Precision Medicines Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth↓ 4/10
  • Value↑ 6/10
Praxis Precision Medicines sales and earnings growth
PRAX Growth
Neutral
  • Revenue Y/Y↓ -100.00%
  • EPS Y/Y↓ -24.12%
  • FCF Y/Y↓ -72.25%
Praxis Precision Medicines gross and profit margin trends
PRAX Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ 514.71%
Praxis Precision Medicines net debt vs free cash flow
PRAX Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Praxis Precision Medicines stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks